Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lockwood

Showing results (81-90 of 489) with videos related to

Pageof 49
Sort By:
JAMA Internal Medicine|February 14, 2018
Admitting What We Do Not Know in Rheumatologic Disease: The First Step Toward Learning MoreMegan M Lockwood, Patrick G O'Malley
British Journal of Obstetrics and Gynaecology|August 1, 1994
Hepatitis C seroconversion in pregnancyM C Zambon, D M Lockwood
Advances in Experimental Medicine and Biology|January 1, 1993
ANCA specificities for HL-60 and neutrophil constituentsS J Jones, C M Lockwood
Advances in Experimental Medicine and Biology|January 1, 1993
Pooled intravenous immunoglobulin in the management of systemic vasculitisD R Jayne, C M Lockwood
Instructional Course Lectures|January 1, 1983
Degenerative spondylolisthesisM D Brown, J M Lockwood
Clinical and Experimental Immunology|November 21, 1997
Studies of epitope restriction on myeloperoxidase (MPO), an important antigen in systemic vasculitisA K Short, C M Lockwood
The British Journal of Dermatology|February 1, 1995
Antineutrophil cytoplasmic antibodies and their relevance to the dermatologistN P Burrows, C M Lockwood
Clinical and Experimental Immunology|March 1, 1996
Azurocidin is a novel antigen for anti-neutrophil cytoplasmic autoantibodies (ANCA) in systemic vasculitisM H Zhao, C M Lockwood
Journal of Immunological Methods|October 16, 1996
A comprehensive method to purify three major ANCA antigens: proteinase 3, myeloperoxidase and bactericidal/permeability-increasing protein from human neutrophil granule acid extractM H Zhao, C M Lockwood
BMJ (Clinical Research Ed.)|August 6, 2005
Model of outcomes of screening mammography: women's decisions about screening depend on many factorsSue M Lockwood, Nicola Bruce, Rosetta Manaszewicz
Pageof 49

Showing results (81-90 of 489) with videos related to

Sort By:
Pageof 49
JAMA Internal Medicine|February 14, 2018
Admitting What We Do Not Know in Rheumatologic Disease: The First Step Toward Learning MoreMegan M Lockwood, Patrick G O'Malley
British Journal of Obstetrics and Gynaecology|August 1, 1994
Hepatitis C seroconversion in pregnancyM C Zambon, D M Lockwood
Advances in Experimental Medicine and Biology|January 1, 1993
ANCA specificities for HL-60 and neutrophil constituentsS J Jones, C M Lockwood
Advances in Experimental Medicine and Biology|January 1, 1993
Pooled intravenous immunoglobulin in the management of systemic vasculitisD R Jayne, C M Lockwood
Instructional Course Lectures|January 1, 1983
Degenerative spondylolisthesisM D Brown, J M Lockwood
Clinical and Experimental Immunology|November 21, 1997
Studies of epitope restriction on myeloperoxidase (MPO), an important antigen in systemic vasculitisA K Short, C M Lockwood
The British Journal of Dermatology|February 1, 1995
Antineutrophil cytoplasmic antibodies and their relevance to the dermatologistN P Burrows, C M Lockwood
Clinical and Experimental Immunology|March 1, 1996
Azurocidin is a novel antigen for anti-neutrophil cytoplasmic autoantibodies (ANCA) in systemic vasculitisM H Zhao, C M Lockwood
Journal of Immunological Methods|October 16, 1996
A comprehensive method to purify three major ANCA antigens: proteinase 3, myeloperoxidase and bactericidal/permeability-increasing protein from human neutrophil granule acid extractM H Zhao, C M Lockwood
BMJ (Clinical Research Ed.)|August 6, 2005
Model of outcomes of screening mammography: women's decisions about screening depend on many factorsSue M Lockwood, Nicola Bruce, Rosetta Manaszewicz
Pageof 49